WORLDSymposium 2016 Keynote Speaker
Dr. Christopher P. Austin’s Keynote Address: Catalyzing Translational Innovation, was presented at the WORLDSymposium 2016. Read speaker bio.
WORLDSymposium 2016 Patient Advocate Leader (PAL) Award
WORLDSymposium 2016 Patient Advocate Leader (PAL) Award was received by Barbara Wedehase. Barbara Wedehase has a Masters in Social Work from Washington University in St. Louis, Missouri and is a Board Certified Genetic Counselor.More details.
WORLDSymposium 2016 Award for Innovation and Accomplishment
WORLDSymposium 2016 Roscoe O. Brady Award was presented to Dr. Emil Kakkis, followed by a scientific presentation by Dr. Kakkis. View details.
WORLDSymposium 2016 New Treatment Award
The WORLDSymposium 2016 New Treatment Award was presented to sebelipase alfa (Kanum™). More details.
WORLDSymposium 2016 Young Investigator Awards
WORLDSymposium was pleased to announce the 8 recipients of the 2016 Young Investigator Awards. Click to view award recipients.
WORLDSymposium 2016 NIH Fellows
Three postdoctoral Lysosomal Disease Network Fellows were selected by the LDN Steering Committee. More Details.
WORLDSymposium 2016 Emerging Trends
For the fourth consecutive year, WORLDSymposium began with Emerging Trends in Lysosomal Biology & Lysosomal Diseases: State-of-the-art for Experts on Monday, February 29, 2016. See agenda and faculty.
WORLDSymposium 2016 Satellite Symposia
9 Satellite symposia were held from Monday, February 29, 2016 to Thursday, March 3, 2016. Click here for the full schedule.
WORLDSymposium 2016 Poster Sessions
WORLDSymposium 2016 had 370 scientific abstracts presented. View 2016 Poster List.
WORLDSymposium 2016 Exhibitors
WORLDSymposium 2016 attracted over 25 Exhibitors and 7 Patient Advocate Groups. View 2016 Exhibitor List.
WORLDSymposium 2016 Program
Following the opening remarks, presentations in the morning and afternoon sessions will discuss innovations in technology and how they can be applied to early diagnosis for lysosomal conditions, progress in gene therapy, and exploitation of differences at the cellular level that may indicate early disease state. On Tuesday, the noon hour is reserved for a meeting with the WORLDSymposia Council of Patient Advocates (COPA)™ that focuses on patient involvement in research planning and subject recruitment. View full program.